D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile

Amyloid Triangles, Squares, and Loops of Apolipoprotein C-III

(2014) Michel de Messieres et al.   BIOCHEMISTRY

Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

(2014) Anders Berg Jørgensen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids

(2013) Laurent Camont et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Apolipoproteins C-I and C-III Inhibit Lipoprotein Lipase Activity by Displacement of the Enzyme from Lipid Droplets

(2013) Mikael Larsson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Pathophysiology and treatment of systemic amyloidosis

(2013) Julian D. Gillmore et al.   Nature Reviews Nephrology

Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

(2013) Teresa Coelho et al.   NEW ENGLAND JOURNAL OF MEDICINE

MappingO-glycosylation of apolipoprotein C-III in MALDI-FT-ICR protein profiles

(2013) Simone Nicolardi et al.   PROTEOMICS

A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates

(2013) Ioanna Tachmazidou et al.   Nature Communications

Statins in the management of dyslipidemia associated with chronic kidney disease

(2012) Murray Epstein et al.   Nature Reviews Nephrology

Hereditary Systemic Amyloidosis Due to Asp76Asn Variant β2-Microglobulin

(2012) Sophie Valleix et al.   NEW ENGLAND JOURNAL OF MEDICINE

HDL Proteome in Hemodialysis Patients: A Quantitative Nanoflow Liquid Chromatography-Tandem Mass Spectrometry Approach

(2012) Alain Mangé et al.   PLoS One

Apolipoprotein CIII Links Dyslipidemia with Atherosclerosis

(2011) Akio Kawakami et al.   Journal of Atherosclerosis and Thrombosis

Uremia Alters HDL Composition and Function

(2011) M. Holzer et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Medullary amyloidosis associated with apolipoprotein A-IV deposition

(2011) Sanjeev Sethi et al.   KIDNEY INTERNATIONAL

The Human Plasma Lipidome

(2011) Oswald Quehenberger et al.   NEW ENGLAND JOURNAL OF MEDICINE

The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: A possible impact on the natural history of the disease

(2010) Marta Marchesi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities

(2010) Anatol Kontush et al.   CURRENT OPINION IN LIPIDOLOGY

HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity

(2009) Amal Zerrad-Saadi et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Stimulation of Cholesterol Efflux by LXR Agonists in Cholesterol-Loaded Human Macrophages Is ABCA1-Dependent but ABCG1-Independent

(2009) Sandra Larrede et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens

(2009) J. A. Vrana et al.   BLOOD

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

(2008) Esther M. M. Ooi et al.   CLINICAL SCIENCE

Structure and Dynamics of Human Apolipoprotein CIII

(2008) Chinthaka Saneth Gangabadage et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Prediction of Aggregation-Prone Regions in Structured Proteins

(2008) Gian Gaetano Tartaglia et al.   JOURNAL OF MOLECULAR BIOLOGY

A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection

(2008) T. I. Pollin et al.   SCIENCE